{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T01:33:39Z","timestamp":1790386419171,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.annder.2021.02.003","type":"journal-article","created":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T03:59:21Z","timestamp":1624507161000},"page":"198-201","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Dupilumab-induced psoriasis and alopecia areata: Case report and review of the literature"],"prefix":"10.1016","volume":"148","author":[{"given":"J.","family":"Beaziz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-D.","family":"Bouaziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Jachiet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Fite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Lons-Danic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.annder.2021.02.003_bib0165","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1056\/NEJMoa1610020","article-title":"Two phase 3 trials of dupilumab versus placebo in atopic dermatitis","volume":"375","author":"Simpson","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annder.2021.02.003_bib0170","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1007\/s12325-017-0542-7","article-title":"The changing landscape of alopecia areata: the therapeutic paradigm","volume":"34","author":"Renert-Yuval","year":"2017","journal-title":"Adv Ther"},{"key":"10.1016\/j.annder.2021.02.003_bib0175","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1056\/NEJMoa1104200","article-title":"Mutual antagonism of T cells causing psoriasis and atopic eczema","volume":"365","author":"Eyerich","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annder.2021.02.003_bib0180","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/exd.13336","article-title":"Systemic immune mechanisms in atopic dermatitis and psoriasis with implications for treatment","volume":"27","author":"Guttman-Yassky","year":"2018","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.annder.2021.02.003_bib0185","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.jdcr.2018.05.014","article-title":"Erythrodermic presentation of psoriasis in a patient treated with dupilumab","volume":"4","author":"Tracey","year":"2018","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.annder.2021.02.003_bib0190","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1111\/ced.13901","article-title":"Psoriasis induced by dupilumab therapy","volume":"44","author":"Safa","year":"2019","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.annder.2021.02.003_bib0195","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/DER.0000000000000509","article-title":"Psoriasis-like dermatitis developing in a patient with atopic dermatitis treated with dupilumab","volume":"30","author":"Stout","year":"2019","journal-title":"Dermatitis"},{"key":"10.1016\/j.annder.2021.02.003_bib0200","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/DER.0000000000000481","article-title":"Psoriasiform dermatitis after initiation of treatment with dupilumab for atopic dermatitis","volume":"30","author":"Fowler","year":"2019","journal-title":"Dermatitis"},{"key":"10.1016\/j.annder.2021.02.003_bib0205","doi-asserted-by":"crossref","first-page":"e12998","DOI":"10.1111\/dth.12998","article-title":"A case of guttate psoriasis during treatment with dupilumab","volume":"32","author":"Gori","year":"2019","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.annder.2021.02.003_bib0210","doi-asserted-by":"crossref","first-page":"e13142","DOI":"10.1111\/dth.13142","article-title":"Occurrence of psoriasiform eruption during dupilumab therapy for adult atopic dermatitis: a case series","volume":"32","author":"Napolitano","year":"2019","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.annder.2021.02.003_bib0215","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1111\/ijd.15003","article-title":"Dupilumab-induced psoriatic erythroderma with characteristic cytokine and antimicrobial peptide expression pattern in a patient with long standing atopic dermatitis","volume":"59","author":"Gambichler","year":"2020","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.annder.2021.02.003_bib0220","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/ced.14207","article-title":"Acute onset of psoriasis in a patient with atopic dermatitis treated with dupilumab","volume":"45","author":"Ferrucci","year":"2020","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.annder.2021.02.003_bib0225","first-page":"1","article-title":"Psoriasis appearing after dupilumab therapy in atopic dermatitis: a case report","volume":"8","author":"Kim","year":"2020","journal-title":"SAGE Open Med Case Rep"},{"key":"10.1016\/j.annder.2021.02.003_bib0230","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jdcr.2020.01.012","article-title":"Dupilumab-induced phenotype switching from atopic dermatitis to psoriasis","volume":"6","author":"Varma","year":"2020","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.annder.2021.02.003_bib0235","first-page":"e13572","article-title":"Exacerbation of psoriasis after initiation of dupilumab in atopic dermatitis patient","author":"Dimitrov","year":"2020","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.annder.2021.02.003_bib0240","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1097\/DER.0000000000000570","article-title":"Psoriatic plaques after initiation of dupilumab therapy","volume":"31","author":"DeGrazia","year":"2020","journal-title":"Dermatitis"},{"key":"10.1016\/j.annder.2021.02.003_bib0245","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s00105-020-04565-8","article-title":"Psoriasis in dupilumab-treated atopic dermatitis","volume":"71","author":"Senner","year":"2020","journal-title":"Hautarzt"},{"key":"10.1016\/j.annder.2021.02.003_bib0250","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jdcr.2018.10.010","article-title":"Drug-induced alopecia after dupilumab therapy","volume":"5","author":"Flanagan","year":"2019","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.annder.2021.02.003_bib0255","doi-asserted-by":"crossref","first-page":"420","DOI":"10.18176\/jiaci.0301","article-title":"Alopecia areata in severe atopic dermatitis treated with dupilumab","volume":"28","author":"Barroso-Garc\u00eda","year":"2018","journal-title":"J Investig Allergol Clin Immunol"},{"key":"10.1016\/j.annder.2021.02.003_bib0260","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jdcr.2017.11.020","article-title":"Alopecia areata after dupilumab for atopic dermatitis","volume":"4","author":"Mitchell","year":"2018","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.annder.2021.02.003_bib0265","first-page":"e41","article-title":"Dermatitis and alopecia in a patient treated with dupilumab: a new adverse effect?","volume":"44","author":"Salg\u00fcero-Fern\u00e1ndez","year":"2019","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.annder.2021.02.003_bib0270","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1684\/ejd.2019.3626","article-title":"Early onset of alopecia areata after dupilumab introduction in a patient with atopic dermatitis","volume":"29","author":"Barbarin","year":"2019","journal-title":"Eur J Dermatol EJD"},{"key":"10.1016\/j.annder.2021.02.003_bib0275","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/DER.0000000000000458","article-title":"Alopecia areata after treatment with dupilumab","volume":"30","author":"Yazdanyar","year":"2019","journal-title":"Dermatitis"},{"key":"10.1016\/j.annder.2021.02.003_bib0280","doi-asserted-by":"crossref","first-page":"e332","DOI":"10.1111\/1346-8138.14880","article-title":"Case of alopecia areata during dupilumab treatment for atopic dermatitis","volume":"46","author":"Kanda","year":"2019","journal-title":"J Dermatol"},{"key":"10.1016\/j.annder.2021.02.003_bib0285","article-title":"Reactivation of alopecia areata after dupilumab therapy for atopic dermatitis","author":"Carnicle","year":"2019","journal-title":"Dermatitis"},{"key":"10.1016\/j.annder.2021.02.003_bib0290","doi-asserted-by":"crossref","first-page":"e13023","DOI":"10.1111\/dth.13023","article-title":"Dupilumab and alopecia: a Janus effect","volume":"32","author":"Patruno","year":"2019","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.annder.2021.02.003_bib0295","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.jdcr.2019.03.019","article-title":"Alopecia areata in 2 patients treated with dupilumab: new onset and worsening","volume":"5","author":"Chung","year":"2019","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.annder.2021.02.003_bib0300","doi-asserted-by":"crossref","first-page":"adv00191","DOI":"10.2340\/00015555-3549","article-title":"Massive acute alopecia of the scalp in a patient treated with dupilumab","volume":"100","author":"Gallo","year":"2020","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.annder.2021.02.003_bib0305","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1111\/jdv.16094","article-title":"Inflammatory alopecia in patients on dupilumab: a retrospective cohort study at an academic institution","volume":"34","author":"Zhu","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.annder.2021.02.003_bib0310","doi-asserted-by":"crossref","first-page":"e612","DOI":"10.1111\/jdv.16493","article-title":"Alopecia areata development in atopic dermatitis patients treated with dupilumab","volume":"34","author":"St\u00e4nder","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.annder.2021.02.003_bib0315","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s40257-018-0383-4","article-title":"Major comorbidities of atopic dermatitis: beyond allergic disorders","volume":"19","author":"Paller","year":"2018","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.annder.2021.02.003_bib0320","article-title":"Cause or cure? Review of dupilumab and alopecia areata","author":"Marks","year":"2019","journal-title":"J Am Acad Dermatol"}],"container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963821000314?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963821000314?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T11:11:04Z","timestamp":1758971464000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0151963821000314"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S0151963821000314"],"URL":"https:\/\/doi.org\/10.1016\/j.annder.2021.02.003","relation":{},"ISSN":["0151-9638"],"issn-type":[{"value":"0151-9638","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dupilumab-induced psoriasis and alopecia areata: Case report and review of the literature","name":"articletitle","label":"Article Title"},{"value":"Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annder.2021.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}